REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaxosmithkline d.o.o. U Likvidaciji (Croatia)

Main Activities: Wholesale Trade Agents and Brokers
Full name: Glaxosmithkline d.o.o. U Likvidaciji Profile Updated: July 14, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

GlaxoSmithKline d.o.o., established in 2004, is the Croatian arm of UK-based pharmaceutical company GlaxoSmithKline. The Croatian company is specialized in the wholesale and distribution of GlaxoSmithKline products, which cover the fields of viral and bacterial infections, neuroscience, respiratory diseases and vaccines. The customer base of GlaxoSmithKline d.o.o. includes drugstores and hospitals across Croatia and abroad.

Headquarters
Damira Tomljanovica - Gavrana 15 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Glaxosmithkline d.o.o. U Likvidaciji report to view the information.

Website: http://www.glaxosmithkline.hr

Basic Information
Total Employees:
Purchase the Glaxosmithkline d.o.o. U Likvidaciji report to view the information.
Outstanding Shares:
Purchase the Glaxosmithkline d.o.o. U Likvidaciji report to view the information.
Incorporation Date:
January 01, 2004
Key Executives
Purchase this report to view the information.
Other
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Glaxosmithkline d.o.o. U Likvidaciji report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HRK. Absolute financial data is included in the purchased report.
Net sales revenue
-31.6%
Total operating revenue
-31.6%
Operating profit (EBIT)
-43.25%
EBITDA
-51.81%
Net Profit (Loss) for the Period
-55.31%
Total assets
-28.06%
Total equity
3.61%
Operating Profit Margin (ROS)
-0.54%
Net Profit Margin
-1.09%
Return on Equity (ROE)
-8.01%
Quick Ratio
4.35%
Cash Ratio
5.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?